Leading US Market Analysis and Research Firm Ranked AnPac Bio Globally Number One in Multi-Cancer Screening and Detection Test Volume
January 25, 2022 07:30 ET
|
AnPac Bio-Medical Science Co., Ltd.
PHILADELPHIA, Jan. 25, 2022 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in the United States and...
Insights on the Lung Cancer Screening Global Market to 2027 - Non-small Cell Lung Cancer Segment Holds Dominant Share
January 25, 2022 06:13 ET
|
Research and Markets
Dublin, Jan. 25, 2022 (GLOBE NEWSWIRE) -- The "Lung Cancer Screening Market, Size, Global Forecast 2022-2027, Industry Trends, Share, Growth, Impact of COVID-19, Opportunity Company Analysis" report...
Insights on the Cancer/Tumor Profiling Global Market to 2030 - Featuring Illumina, Guardant Health and Qiagen Among Others
January 25, 2022 05:28 ET
|
Research and Markets
Dublin, Jan. 25, 2022 (GLOBE NEWSWIRE) -- The "Cancer/Tumor Profiling Market by Technique, by Technology and by Application - Global Opportunity Analysis and Industry Forecast 2021-2030" report has...
Biomerica Reports Record Financial Results for Fiscal Second Quarter ended November 30, 2021
January 13, 2022 08:19 ET
|
Biomerica, Inc.
Revenues up 239% over prior year fiscal second quarter Customer orders backlog of over $4.0 million at November 30, 2021 Walmart began in-store and online sales of Biomerica’s EZ Detect™ Colon...
AnPac Bio Class III Medical Device Passes Extensive NMPA Registration Tests and Will Start Clinical Trial in Q1, 2022
January 04, 2022 07:30 ET
|
AnPac Bio-Medical Science Co., Ltd.
PHILADELPHIA, Jan. 04, 2022 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a US and China-based biotechnology company focused on early cancer...
Insights on the Lung Cancer Diagnostics Global Market to 2027 - Featuring Illumina, Abbott Laboratories and Thermo Fisher Scientific Among Others
December 30, 2021 04:23 ET
|
Research and Markets
Dublin, Dec. 30, 2021 (GLOBE NEWSWIRE) -- The "Lung Cancer Diagnostics Market Size, Share, Global Forecast 2022-2027, Industry Trends, Impact of COVID-19, Opportunity Company Analysis" report has...
The Colorectal Cancer Screening Market is Expected to Register a CAGR of 5.4% in the Forecast Period of 2021-2026
December 23, 2021 06:33 ET
|
Research and Markets
Dublin, Dec. 23, 2021 (GLOBE NEWSWIRE) -- The "Colorectal Cancer Screening Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)" report has been added to ResearchAndMarkets.com's...
United States and Canada Cervical Cancer Screening Industry Forecast to Reach US$ 8.2 Billion by 2027
December 13, 2021 04:18 ET
|
Research and Markets
Dublin, Dec. 13, 2021 (GLOBE NEWSWIRE) -- The "United States and Canada Cervical Cancer Screening Market, Forecast 2022-2027, Industry Trends, Impact of COVID-19, Company Analysis" report has been...
Technical Paper on AnPac Bio Novel CDA Cancer Detection Technology Published by Peer-Reviewed International Medical Journal
December 10, 2021 07:30 ET
|
AnPac Bio-Medical Science Co., Ltd.
PHILADELPHIA, Dec. 10, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...
CORRECTION -- Anpac Bio, USA
November 11, 2021 03:19 ET
|
Anpac Bio, USA
PHILADELPHIA, Nov. 11, 2021 (GLOBE NEWSWIRE) -- In its press release dated November 9, 2021 entitled “AnPac Bio Announces Pricing of Approximately $2.9 Million Underwritten Public Offering of...